NCT04682483 - Cardiogenic Shock Working Group Registry | Biotech Hunter

Enrollment

5,000

Participants

Timeline

Start Date

December 4, 2017

Primary Completion Date

January 1, 2026

Study Completion Date

June 1, 2026

Conditions

Cardiogenic Shock

Interventions

DRUG

Vasopressor

The vasopressors include phenylephrine, norepinephrine, epinephrine, dopamine and vasopressin.

DRUG

Inotrope

Inotropes include dobutamine and milrinone.

DEVICE

Acute Mechanical Circulatory Support Devices

Acute Mechanical Circulatory Support devices include ECMO (VV), ECMO (VA), Impella CP, Impella 2.5, Impella 5.0, Impella 5.5, Impella RP, IABP, Centrimag, Tandem Heart and ProTek Duo.

Trial Locations (16)

10032

RECRUITING

Columbia University Irving Medical Center, New York

15212

RECRUITING

Allegheny General Hospital, Pittsburgh

15261

RECRUITING

University Of Pittsburgh Medical Center, Pittsburgh

22042

RECRUITING

Inova Health System, Falls Church

33331

RECRUITING

Cleveland Clinic Florida, Weston

60611

RECRUITING

Northwestern Medicine, Chicago

60612

RECRUITING

University of Chicago, Chicago

75201

RECRUITING

Baylor Scott & White Advanced Heart Failure Clinic, Dallas

77030

RECRUITING

Houston Methodist Hospital, Houston

77555

RECRUITING

University of Texas Medical Branch, Galveston

97225

RECRUITING

Providence St. Vincent Heart Clinic, Portland

04102

RECRUITING

Maine Medical Center, Portland

02111

RECRUITING

Tufts Medical Center, Boston

02215

RECRUITING

Beth Israel Deaconess Medical Center, Boston

07601

RECRUITING

Hackensack Meridian Health, Hackensack

98195-9472

RECRUITING

University of Washington Medical Center, Seattle